Microglia‐derived Galectin‐9 drives amyloid‐β pathology in Alzheimer's disease

Documenti analoghi

• Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice
  di: Wanhong Han, et al.
  Pubblicazione: (2024)
• Aβ ‐induced excessive mitochondrial fission drives type H blood vessels injury to aggravate bone loss in APP/PS1 mice with Alzheimer's diseases
  di: Weidong Zhang, et al.
  Pubblicazione: (2024)
• Galectin‐9 high Neutrophils Exacerbate Radiation‐Induced Frailty
  di: Zhuo Cheng, et al.
  Pubblicazione: (2026)
• Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease
  di: Yuting Cui, et al.
  Pubblicazione: (2024)
• RUVBL2 Regulates Microglia Metabolic Reprogramming to Mediate Stress Granules Aggregation Exacerbating Postoperative Delirium in Aged Mild Cognitive Impairment Rats
  di: Lin Zhang, et al.
  Pubblicazione: (2026)